ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 657305 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 657305; 2) Community: the network communities that were significantly associated with the response to NSC 657305; 3) Molecule: the relationships between components within communities and NSC 657305; 4) MDR: the compounds that were significantly associated with the NSC 657305.

NSC Compound Enrichment Correlation
NSC 649150 Null 0.0376362543535815 0.25000323
NSC 102627 Yoshi 864 0.0382675857669585 0.26485433
NSC 105808 5,8-Quinolinedione, 6-amino-7-bromo- 0.0382675857669585 0.48269983
NSC 10660 Null 0.0382675857669585 0.11532599
NSC 154572 Null 0.0382675857669585 0.25920986
NSC 175630 Toyocamycin, 6-amino- 0.0382675857669585 0.036187463
NSC 212509 Ergosta-2,24-dien-26-oic acid, 5,6-epoxy-4,14,17,20,22-pentahydroxy-1-oxo-, .delta.-lactone, (4.beta.,5.beta.,6.beta.,17.alpha.,22R)- (9CI) 0.0382675857669585 0.26978434
NSC 240419 Benzoic acid, 2-[[4-[bis(2-bromopropyl)amino]-2-methylphenyl]azo]- 0.0382675857669585 0.23960017
NSC 338947 Clomesone 0.0382675857669585 0.32829353
NSC 353500 Null 0.0382675857669585 0.28886433
Total:71  Current:56    [First] [Prev] [Next] [Last]